G protein-coupled receptor

Adenosine A2A receptor

Adenosine A2A receptor

  • GeneADORA2A
  • FamilyAdenosine receptors
  • GroupAdenosine receptors

The A2A receptor first appeared in 1990 as an orphan, a seven-transmembrane receptor without a known ligand, called RDC8. When a group in Brussels expressed it in adrenal Y1 cells, in dog thyroid cells and in Xenopus oocytes, adenylyl cyclase and the cyclic AMP cascade switched on without any added signal. The adrenal cells rounded up, the thyroid cells sprouted processes, rounded up and went into DNA synthesis (45 percent of the injected cells took up labelled thymidine, against 3 percent of the controls), and the oocytes held about 31 picomoles of cyclic AMP per ten oocytes against 18 in the controls. The activity was largely suppressed by adenosine deaminase, which removes adenosine, and in Cos-7 cells RDC8 acquired the binding behavior of an A2 receptor. The authors concluded that RDC8 codes for an adenosine A2 receptor and left open whether its constitutive activity comes only from adenosine that the cells make themselves or also from the receptor.1

Two years later a second group found the human receptor by a deliberate search. Degenerate primers built on conserved parts of the transmembrane regions of G protein-coupled receptors amplified related sequences from a human neuroblastoma library, and one fragment was used to pick a full-length clone from a human hippocampal library. It encodes a protein of 412 amino acids that is 92.7 percent homologous to RDC8, by then identified as the A2a receptor of the dog thyroid. In stably transfected human embryonic kidney cells the receptor bound adenosine agonists and antagonists with the affinities of a brain A2a receptor, and the selective agonist CGS21680 raised cyclic AMP without changing the calcium concentration in the cells.2

In the brain the receptor sits where dopamine is. Receptor binding and messenger RNA both place A2A receptors in the dopamine-rich regions, and with a selective antagonist as the radioligand there is little binding outside the striatum, the nucleus accumbens and the olfactory tubercle. Very little messenger RNA is found elsewhere, which the authors of a review of caffeine in the brain find surprising given the functional evidence for A2A receptors in hippocampus and cortex. In the dorsal striatum the messenger RNA of the receptor sits together with that of the D2 receptor in medium-sized spiny neurons that make enkephalin, while the neurons with D1 receptors and substance P do not express it. Most studies also found no A2A messenger RNA in the large cholinergic interneurons. The receptor associates with Gs proteins, so that its activation switches on adenylyl cyclase, and A1 and A2A receptors have partly opposing actions at the cellular level.3

Human and rat A2A receptors are close relatives but not identical twins. Kull and colleagues compared the human receptor in CHO cells with the rat receptor that PC12 cells make themselves. The antagonist radioligand SCH 58261 bound with a dissociation constant of 1.05 nM in the CHO cells and 5.6 nM in the PC12 cells (maximal binding 538 and 2,085 fmol per mg), and the antagonists, among them caffeine, were ranked in the same order and were approximately equipotent in the two cells. Among the agonists, 2-phenylaminoadenosine and 2-chloroadenosine were more potent at the human receptor than the rat data predicted, and in the cyclic AMP assay all agonists were more potent in the CHO cells, which differences in adenylyl cyclase or in G proteins did not readily explain. A review of the actions of caffeine gives a similar example, CGS 21680 has an affinity close to 100 nM at the human receptor in CHO cells and closer to 10 nM at the rat receptor. The order of potency of agonists can thus differ between species homologues of the receptor even where the antagonist pharmacology does not.4,3

Mice without the receptor, made by Ledent and colleagues in 1997, appeared normal and bred normally, although the animals of both sexes weighed more from the age of three months. In the striatum the loss lowered the messenger RNA of protachykinin by about 30 percent and that of proenkephalin by about 12 percent. The mice explored less, scored higher in anxiety tests, and the males were much more aggressive towards intruders. Caffeine, which normally stimulates exploration, reduced it in the knockouts, and the selective agonist CGS 21680 lost its activity in every system tested. The animals responded more slowly to acute pain, and their blood pressure, heart rate and platelet aggregation were higher, which the authors read as a tonic vasodilating effect of endogenous adenosine.5

Caffeine, the best-known antagonist of the receptor, blocks the effects of adenosine at A2A receptors, where it is most potent, and at A1 receptors already at the low concentrations reached after a single cup of coffee. The authors of the review conclude that the only known mechanism significantly affected by the relevant doses of caffeine is binding to adenosine receptors and antagonism of the actions of agonists at these receptors, and that the effects of caffeine on dopaminergic transmission are exerted mainly via A2A receptors.3

Sources (5)
  1. Maenhaut et al. 1990Maenhaut C, Van Sande J, Libert F, et al. (1990) RDC8 codes for an adenosine A2 receptor with physiological constitutive activity Biochem Biophys Res Commun
  2. Furlong et al. 1992Furlong TJ, Pierce KD, Selbie LA, et al. (1992) Molecular characterization of a human brain adenosine A2 receptor Brain Res Mol Brain Res
  3. Fredholm et al. 1999Fredholm BB, Bättig K, Holmén J, et al. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev
  4. Kull et al. 1999Kull B, Arslan G, Nilsson C, et al. (1999) Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors Biochem Pharmacol
  5. Ledent et al. 1997Ledent C, Vaugeois JM, Schiffmann SN, et al. (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor Nature

Binding affinity (Kᵢ)

1 substance, 2 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

1 measurement
  • Caffeine8182 nMKull et al. 1999
    Assay
    CHO cells expressing human A2A, [3H]SCH 58261 displacement
    Shown value from
    Kull et al. 1999, Table 1

Rat

1 measurement

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.